Randomized controlled trialHumanClinical Trial, Phase III
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial
JAMA, 2021 Apr 13. Rubino D, Abrahamsson N, Davies M and 12 others.
Study type
Randomized controlled trial · Clinical Trial, Phase III
Subjects
Human participants (PubMed MeSH: Humans)
Journal
JAMA
Published
2021 Apr 13
PubMed
Indexed under
MeSH terms assigned by the National Library of Medicine.
AdultAnti-Obesity AgentsBlood PressureDouble-Blind MethodFemaleGlucagon-Like Peptide 1Glucagon-Like PeptidesHumansInjections, SubcutaneousMaleMiddle AgedObesity
PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page